glp-1 news today 2025 Pharmacy Pricing Update (Dec 2025) obesity drug news today glp-1

Ozempic can be difficult to get and isn't appropriate for everyone

Learn how they work, who theyre for, and the truth about microdosing.

And when progress slows, patients look elsewhere

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications that have gained significant attention in recent years for their ability to manage blood sugar levels and promote weight loss

TIIDM is primarily found in middle-aged and elderly individuals

The Food and Drug Administration (FDA) on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, is no longer in short supply. | The demand for weight loss drugs is not slowing down, and many organizations voiced concerns there will likely be semaglutide shortages in the future that will impact patients' access to weight loss medications.